Download Mapping a route for the commercialisation of regenerative medicine

Lord Krebs, Chairman of the House of Lords Science and Technology Committee joined us last year at the World Stem Cells & Regenerative Medicine Congress to present on ‘Mapping a route for the commercialisation of regenerative medicine; The House of Lords Science and Technology Committee’s Regenerative Medicine Inquiry.’ Download this presentation now to find out more about: Purpose of the …

Bringing stem cell research to the market as commercial therapies

“There’s nothing like a live conference…you can set up both formal and informal meetings” – Keith Thompson, CEO, Cell Therapy Catapult Increased collaboration and lowering the barriers to finding investment are two of the most crucial goals for the global stem cell and regenerative medicine industry over the coming years if it is to translate cutting edge science into commercialised …

Increasing struggles in cell therapies manufacturing as production ramps up

Even though there has been an increasing number of cell therapies advancing to late-stage clinical development, several aspects of cell therapy development continue to present considerable challenges for large scale commercialization. It is clear that production of biologics in general carries higher risks than of small molecules pharmaceuticals and this becomes even more evident as production of cell therapies ramps …

5 Leading Presentations from the 7th Annual World Stem Cells & Regenerative Medicine Congress

  With the buzz growing for the 8th Annual World Stem Cells & Regenerative Medicine Congress later this month, we wanted to take a look back at some of the leading presentations, debates and discussions that took place at last year's event.     This eBook contains 5 of the leading presentations from last year's congress that cover: Lessons learned …

Download: Lonza’s Commercial Cell Therapies & Cell Characterisation Presentation

Question: Are we reaching an inflection point for the stem cell and regenerative medicine industry? While the therapeutic potential of stem cells may not fully impact healthcare for a number of years, the current concern is to ensure the roadmap for cell therapy commercialisation is debated by the industry at large and early mistakes by pioneers are quickly learnt and …